| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8924158 | JMV-Journal de Médecine Vasculaire | 2018 | 8 Pages |
Abstract
Given the context of economic restriction and the TTR of our cohort close to the recommended 70%, there would be no benefit in terms of safety to prefer DOAC for the patients involved in this study. Regular monitoring of the individual patient's as well as the cohort's TTR should optimize the management of patients receiving VKAs.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
E. Valdelièvre, I. Quéré, B. Caré, J.P. Laroche, J.F. Schved,